Metzker Partners

Pulmotect, Inc., based in Houston, TX, is a biotechnology company focused on harnessing the innate immune system to protect the lungs from viral, bacterial, and fungal pathogens. Its lead product, PUL-042, is an inhaled therapeutic currently in clinical stages, demonstrating strong potential in providing immediate protection and therapeutic benefits for at-risk populations. Initial clinical trials have shown that PUL-042 is well tolerated among diverse patient groups, including healthy individuals and those with chronic obstructive pulmonary disease (COPD). Future studies aim to further assess its effectiveness in preventing respiratory complications and improving outcomes for immunocompromised cancer patients, along with individuals suffering from COPD, asthma, and seasonal infections. Generated from the website

Ligandomicsrx, LLC is a biotechnology company based in Houston, TX that specializes in developing innovative solutions for personalized medicine. With a focus on molecular diagnostics and drug development, the company is dedicated to advancing healthcare through cutting-edge research and technology. Generated from their business information

Everglades Biopharma LLC is a Houston-based company specializing in the development of ligand-based therapies. Their innovative proprietary technology, ligandomics, allows for the systematic identification of disease-specific cellular ligands as therapeutic targets, resulting in therapies with higher efficacy and fewer side effects. With a focus on neovascular disease conditions, Everglades Biopharma is currently developing a therapeutic antibody that targets a novel angiogenic ligand upregulated in these conditions, offering potential treatments for neovascular age-related macular degeneration (AMD), diabetic macular edema, and cancer.Generated from the website